巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Evoke Pharma

    EVOK
    1.870
    0.010
    0.53%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Evoke Pharma - 延遲價格・最後更新於 30/09 8:28
    最高位
    1.930
    最低位
    1.870
    開市價
    --
    前收市價
    1.880
    成交量(千)
    0.07
    成交額(百萬)
    0.00
    買入
    1.480
    賣出
    2.570
    每手股數
    --
    市值(百萬)
    6.25
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    17.400 - 1.800
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Evoke Pharma
    證券代碼
    EVOK.US
    所屬板塊
    Drug Manufacturers - Specialty & Generic
    公司業務
    Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
    發行量
    32917901
    公司總部
    420 Stevens Avenue, Suite 370
    公司網址
    https://www.evokepharma.com
    公司電話
    +1 858 345-1494
    暫無內容

    關於

    Evoke Pharma(EVOK.US)所屬的行業板塊為Drug Manufacturers - Specialty & Generic。
    Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
    詳細公司背景可參考: https://www.evokepharma.com